Search by Drug Name or NDC

NDC 00093-8076-56 Tiagabine Hydrochloride 16 mg/1 Details

Tiagabine Hydrochloride 16 mg/1

Tiagabine Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is TIAGABINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Tiagabine is used in combination with other medications to treat partial seizures (a type of epilepsy). Tiagabine is in a class of medications called anticonvulsants. It is not known exactly how tiagabine works, but it increases the amount of natural chemicals in the brain that prevent seizure activity.

Related Packages: 00093-8076-56
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tiagabine

Product Information

NDC	00093-8076
Product ID	0093-8076_774a4b2f-e96b-4d6a-a9ff-122279d46b6f
Associated GPIs	72170070100320
GCN Sequence Number	034739
GCN Sequence Number Description	tiagabine HCl TABLET 16 MG ORAL
HIC3	H4B
HIC3 Description	ANTICONVULSANTS
GCN	37982
HICL Sequence Number	015773
HICL Sequence Number Description	TIAGABINE HCL
Brand/Generic	Generic
Proprietary Name	Tiagabine Hydrochloride
Proprietary Name Suffix	n/a
Non-Proprietary Name	Tiagabine Hydrochloride
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	16
Active Ingredient Units	mg/1
Substance Name	TIAGABINE HYDROCHLORIDE
Labeler Name	Teva Pharmaceuticals USA, Inc.
Pharmaceutical Class	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA Schedule	n/a
Marketing Category	NDA AUTHORIZED GENERIC
Application Number	NDA020646
Listing Certified Through	2024-12-31

Package

NDC 00093-8076-56 (00093807656)

Pricing Information	N/A
NDC Package Code	0093-8076-56
Billing NDC	00093807656
Package	30 TABLET, FILM COATED in 1 BOTTLE (0093-8076-56)
Marketing Start Date	2018-03-09
NDC Exclude Flag	N